WhatsApp
backNews Article

Vijaya Diagnostic Centre Reports Rs 24,200.20 Lakh Revenue in Q2 2026 and Appoints Rahul Jain as Company Secretary

Results for quarter ended September 30, 2026 approved alongside key management personnel appointment effective November 3, 2026

Vijaya Diagnostic Centre Limited announces unaudited standalone and consolidated financial results for Q2 ended September 30, 2026, showing operating revenue of Rs 24,200.20 lakh. The company appoints Rahul Jain as Company Secretary and Compliance Officer effective November 3, 2026, strengthening its compliance team.

16 hours ago|VIJAYA-1.55%
Vijaya Diagnostic Centre LimitedVIJAYAFinancial Results

Vijaya Diagnostic Centre Limited

Financial Results

Vijaya Diagnostic Centre Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, with operating revenue of Rs 24,200.20 lakh for the quarter. During the same board meeting, Mr. Rahul Jain was appointed as the Company Secretary and Compliance Officer, effective November 3, 2026.

The unaudited financial results show total income of Rs 24,745.11 lakh for the quarter ended September 30, 2026, including other income of Rs 544.91 lakh. Expenses during the quarter included cost of materials consumed at Rs 2,722.36 lakh, employee benefits expense at Rs 3,597.96 lakh, finance costs of Rs 1,082.13 lakh, and depreciation and amortisation expense of Rs 2,398.80 lakh.

The Board meeting was conducted on November 3, 2026, starting at 6:12 PM IST and concluding at 6:40 PM IST. The appointment of Mr. Rahul Jain as Company Secretary and Compliance Officer was based on the recommendation of the Nomination and Remuneration Committee and complies with Section 203 of the Companies Act 2013 and SEBI Listing Regulations.

Mr. Rahul Jain is a qualified Company Secretary with over six years of experience in corporate secretarial functions, compliance, and governance for listed companies. His expertise includes corporate and securities law compliance, regulatory disclosures, and corporate governance matters.

Highlights

  • Unaudited Q2 2026 revenue from operations of Rs 24,200.20 lakh
  • Total income for Q2 2026 at Rs 24,745.11 lakh including other income
  • Key expenses include Rs 2,722.36 lakh in material costs and Rs 3,597.96 lakh in employee benefits
  • Appointment of Mr. Rahul Jain as Company Secretary and Compliance Officer effective November 3, 2026
  • Mr. Rahul Jain brings over six years of relevant professional experience
  • Board meeting held on November 3, 2026, lasted 28 minutes

Key Data Snapshot

Revenue from operations for Q2 ended September 30, 2026Rs 24,200.20 lakh
Total income for Q2 ended September 30, 2026Rs 24,745.11 lakh
Cost of materials consumed for Q2Rs 2,722.36 lakh
Employee benefits expense for Q2Rs 3,597.96 lakh
Finance costs for Q2Rs 1,082.13 lakh
Depreciation and amortisation expense for Q2Rs 2,398.80 lakh
Appointment date of Company SecretaryNovember 3, 2026
Name of appointed Company SecretaryMr. Rahul Jain

What happened

  • Vijaya Diagnostic Centre approved unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
  • Total revenue from operations reported at Rs 24,200.20 lakh for Q2 2026.
  • Mr. Rahul Jain appointed as Company Secretary and Compliance Officer with effect from November 3, 2026.
  • Board meeting held on November 3, 2026, from 6:12 PM to 6:40 PM IST.

Key details

  • Mr. Rahul Jain is a qualified Company Secretary and Associate Member of the Institute of Company Secretaries of India.
  • He has over six years of experience in corporate secretarial functions and regulatory compliance for listed companies.
  • His expertise covers Companies Act 2013, SEBI Listing Regulations, Insider Trading, Substantial Acquisition and Takeovers Regulations, FEMA, and other legal frameworks.
  • The appointment is pursuant to Section 203 of the Companies Act 2013 and SEBI Listing Obligations and Disclosure Requirements Regulations.
  • The registered auditor, B S R and Co Chartered Accountants, conducted a limited review of the financial results with no material misstatements reported.

Regulatory and governance context

  • Financial results prepared in accordance with Indian Accounting Standard 34 and comply with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
  • Amalgamation of Medinova Diagnostic Services Limited accounted for in the financial results as per NCLT order dated October 13, 2025.
  • Disclosure made under Regulation 30 of SEBI Listing Regulations regarding appointment of key managerial personnel.

More News on Financial Results

View all

Latest corporate announcements and market updates in Financial Results.

View all news
Vijaya Diagnostic Centre Reports Rs 24,200.20 Lakh | Stockk News